CKD and CHF: the Silent Threat

ASN Renal Week, October, 2004

Welcome, Introduction and Program Overview



Bob Provenzano, MD
Please make sure that all slide images load before starting the lecture

Windows Media Player
Option 1 Streaming Server
Option 2 For slow connections, right click on preload icon and choose "save target as". Play file from saved location.

Real Audio Player
Option 3 Streaming, Firewall-friendly
Option 4 Preload (2-5 mB)

Audio FAQ
For problems and suggestions, please click on this link.
This group of talks is accredited for 2.0 CME Category 1 credits for physicians by the American Society of Nephrology. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain continuing education credit.
Date of Web Release: March, 2005
CME Category 1 Credit Eligible Through: May 1, 2006
CME Category 1 Credits/Completion Time: 2.0
Target Audience: Practicing nephrologists and internists.
Method of participation: Listen to the talk(s), read the PubMed abstracts of linked slides and references, take the post-test, read the abstracts linked to in the post-test feedback section.
 
SPONSORSHIP/SUPPORT:
This official symposium was sponsored by a restricted educational grant from Ortho Biotech Products, LP.
LEARNING OBJECTIVES:
The educational objectives for this talk are presented on the conference page. To view the objectives, click here.

SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE:
Dr. Provenzano: consultant: Amgen, Ortho-Biotech, Roche; scientific advisor: Amgen, Ortho-Biotech, Roche; honoraria: Amgen.
No disclosed off-label use.

ASN ACCREDITATION AND DESIGNATION STATEMENTS:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ASN designates this educational activity for a maximum of 2.0 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA category 1 credit.

Additional CME policy statements of the ASN, which is the accrediting organization for this talk, are given in detail on the ASN Renal Week Home Page, including Disclaimer and User Instructions.

HDCN CE POLICY STATEMENTS:
The CME policy statements of HDCN are listed on this page.


Dr. Bob Provenzano
Good evening and welcome to St. Louis. My name is Bob Provenzano from Detroit, and I am pleased to moderate this session this evening.

As you know, tonight’s talk is going to be on CKD and CHF - the silent threat. Obviously, this builds on a lot of work by many researchers in this area. As ESRD continues to grow at epidemic rates, many of us have focused upstream, and one of those focuses has included anemia in CHF.

Our speakers tonight are going to touch on all of these subjects and bring it together in a clinical manner that will serve you well back home in your practices

Thank you very much.



TO GO TO FIRST TALK by Donald Silverberg CLICK HERE



BACK TO
TOPIC INDEX :